New partnership with Myasthenia Gravis Foundation of America
The PAN Foundation and the Myasthenia Gravis Foundation of America announced today that they are launching a new partnership to help people living with myasthenia gravis, providing up to $13,000 per year in financial assistance and support services for patients and their loved ones.
Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles, which the body uses for breathing and movement. According to the National Institute of Neurological Disorders and Stroke, approximately 132,400 people are living with myasthenia gravis in the U.S.
“Myasthenia gravis is a lifelong diagnosis, and though there are effective treatments, they often come with high out-of-pocket responsibility for those affected,” said PAN President and CEO Kevin L. Hagan. “We are grateful for this new partnership with the Myasthenia Gravis Foundation of America, which will allow our patients to access education, support groups, research updates, and other resources.”
The Myasthenia Gravis Foundation of America (MGFA) is committed to finding a cure for myasthenia gravis and closely related disorders.
“For people with MG, symptoms present in a variety of ways and may include severe weakness that can make standing or speaking difficult. Living with MG can be debilitating for many, and it is our goal to help patients minimize this burden and to assist them to live a better quality of life over time,” said MGFA CEO Samantha Masterson. “We are thrilled to begin this partnership with the PAN Foundation, to better support patients with MG holistically. PAN’s help to alleviate financial worries will allow patients to focus on their quality of life.”
Patients who qualify for the PAN Foundation Myasthenia Gravis Fund are eligible to receive $13,000 per year in financial assistance.
Eligibility requirements
To get financial assistance for myasthenia gravis, patients must:
- Be getting treatment for myasthenia gravis.
- Have Medicare health insurance that covers the qualifying medication or product.
- Have an income that falls at or below 400 percent of the federal poverty level.
About the PAN Foundation
The PAN Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic, and rare diseases with the out-of-pocket costs for their prescribed medications.
Since 2004, we have provided more than 1 million underinsured patients with $4 billion in financial assistance. Partnering with generous donors, healthcare providers, and pharmacies, we provide the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. Learn more at panfoundation.org.
About the Myasthenia Gravis Foundation of America
The Myasthenia Gravis Foundation of America (MGFA) is the leading patient advocacy organization solely dedicated to finding a cure and improved treatments for the rare neuromuscular disease myasthenia gravis (MG) by funding critical research discoveries and providing patient-centric programs, guidance, events, and webinars to connect, educate, and assist members of the global MG community. You can visit MGFA at myasthenia.org.
People with serious health conditions—and their families and caregivers—need support beyond financial assistance.
Learn more
Was this helpful?